Tomorrow: How ESG Drives Trust Among Investors and Patients Alike
|
Hi! A reminder that tomorrow (Friday the 13th!) at noon ET / 9 a.m. PT / 4 p.m. GMT we’re continuing our T2B IR Roundtable programming with a session on Environmental, Social, and Governance (ESG) strategies: Beyond the Checkbox: How ESG Drives Trust Among Investors and Patients AlikeWe’ll explore practical insights and considerations for biopharma companies at every stage of their ESG journey:
How to registerT2B Pro and Student Members can sign up for free (Basic members not permitted). About the speakers and the IR RoundtableThis program features members of our IR Roundtable and guest experts sharing their perspectives:
The T2B IR Roundtable was designed to explore how communications and investor relations leaders are navigating evolving expectations across stakeholders, including investors, patients, and employees. If you might be interested in joining Year 2 of the roundtable, applications will open next month! Hope to see you tomorrow! Lynnea |
T2B Monthly
Hi! While our field has its own regulatory, scientific, and stakeholder complexities, many of the judgment calls we face around trust, executive counsel, reputation, and change aren’t unique to biotech. Communicators in other highly scrutinized sectors often navigate similar pressures, often with lessons that translate in useful ways. Tomorrow’s Comm Convo brings together communications leaders who have worked both inside and outside of biopharma. They’ll share how working in other industries...
Hi, and Happy Friday! At our Q1 IR Roundtable event, How ESG Drives Trust Among Investors and Patients Alike, our guest speakers dug into ESG with a biopharma lens, exploring how we can approach ESG in a way that strengthens credibility. ESG is most effective when it helps stakeholders understand how a company manages risk and makes decisions, rather than being positioned as a separate corporate responsibility exercise. If you weren’t able to join us live, T2B Pro and Student members can...
Hi! At our very first Patient Advocacy & Engagement Roundtable discussion, Patient Stories Without a Fixed Address, the conversation with leaders from Astellas, Bayer, and Atrium Therapeutics focused on what patient centricity looks like when it is treated as a strategic business priority. A consistent theme emerged: Organizations that build strong patient relationships tend to do so by embedding patient perspectives early, operationalizing what they hear, and protecting the integrity of the...